The surgical approach to management of testis cancer has been traditionally through an open incision, but in the last decade, several centers have reported their experience with laparoscopic retroperitoneal lymph node dissection (LRPLND).
Methods
We reviewed the English literature, summarized the outcomes, and included our initial experience with the LRPLND procedure.
Results
Improvements in operative time, complications, and morbidity have occurred as surgical experience has increased. The procedure is more challenging in postchemotherapy patients. Outcomes at our institute are comparable to reported series from other institutions, and LRPLND is our current procedure of choice for RPLND.
Conclusions
LRPLND has been shown to be a safe, effective, minimally invasive procedure in the management of testicular cancer patients who require surgery to address the retroperitoneal lymph nodes.
References
1.
JemalA., SiegelR., WardE.. Cancer statistics, 2007.CA Cancer J Clin.2007; 57: 43–66.
2.
NeyerM., PeschelR., AkkadT.. Long-term results of laparo-scopic retroperitoneal lymph-node dissection for clinical stage I nonsemino-matous germcell testicular cancer.J Endourol.2007; 21: 180–183.
3.
RukstalisD.B., ChodakG.W.. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma.J Urol.1992; 148: 1907–1910.
4.
StoneN.N., SchlusselR.N., WaterhouseR.L.. Laparoscopic retroperitoneal lymph node dissection in stage A nonseminomatous testis cancer.Urology.1993; 42: 610–614.
5.
CastilloO., WohlerC., MayanzM.. Laparoscopic lumboaortic retroperitoneal lymphadenectomy in testicular neoplasm. [Article in Spanish.]Rev Med Chil.1994; 122: 313–318.
AlbqamiN., JanetschekG.. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer.J Endourol.2005; 19: 683–692.
14.
AlbersP., SienerR., KlieschS.. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.J Clin Oncol.2003; 21: 1505–1512.
15.
AmatoR.J., RoJ.Y., AyalaA.G.. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.Urology.2004; 63: 144–149.
16.
WeissbachL., BoedefeldE.A.. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I.J Urol.1987; 138: 77–82.
17.
NarayanP., LangeP.H., FraleyE.E.. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer.J Urol.1982; 127: 685–688.
18.
DonohueJ.P., FosterR.S., RowlandR.G.. Nerve-sparing retroperi-toneal lymphadenectomy with preservation of ejaculation.J Urol.1990; 144(2 Pt 1): 287–292.
19.
PeschelR., GettmanM.T., NeururerR.. Laparoscopic retroperi-toneal lymph node dissection: description of the nerve-sparing technique.Urology.2002; 60: 339–343.
20.
CulineS., DrozJ.P.. Primary treatment in stage II non-seminomatous germ cell tumours of the testis: a matter of scalpel or drug infusion?Eur J Cancer.1996; 32A: 1641–1644.
21.
LeBlancE., CatyA., DargentD.. Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results.J Urol.2001; 165: 89–92.
22.
WeissbachL., Bussar-MaatzR., FlechtnerH.. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment.Eur Urol.2000; 37: 582–594.
23.
RabbaniF., SheinfeldJ., Farivar-MohseniH.. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.J Clin Oncol.2001; 19: 2020–2025.
24.
XiaoH., SheinfeldJ., MotzerR.J.. Adjuvant chemotherapy for testicu-lar cancer.Surg Oncol Clin N Am.1997; 6: 863–878.
25.
PoharK.S., RabbaniF., BoslG.J.. Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis.J Urol.2003; 170(Pt 1): 1155–1158.
26.
DonohueJ.P.. Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT).Urol Oncol.2003; 21: 129–12.
27.
DonohueJ.P., RowlandR.G.. The role of surgery in advanced testicu-lar cancer.Cancer.1984; 54(11 suppl): 2716–2721.
SteinerH., PeschelR., JanetschekG.. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.Urology.2004; 63: 550–555.
30.
JanetschekG., HobischA., HoltlL.. Retroperitoneal lym-phadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopy versus open surgery and impact of learning curve.J Urol.1996; 156: 89–94.
DonohueJ.P., ThornhillJ.A., FosterR.S.. Retroperitoneal lym-phadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.J Urol.1993; 149: 237–243.
33.
EggenerS.E., CarverB.S., SharpD.S.. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.J Urol.2007; 177: 937–943.
34.
HoltlL., PeschelR., KnappR.. Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels.Urology.2002; 59: 114–118.
